Healthequity price to free cash flow HQY

Market value divided by free cash flow over the last twelve months, since 2015.

Today, Oct 23, 2026: 17.6×
10-year median: 36.6×
Against its 10-year history: 7th; percentile: 0 is its lowest day, 100 its highest
10-year range: 14.5× to 79.8×
Peer median: 14.7×

Healthequity's price to free cash flow is 17.6× as of Oct 23, 2026.

That is below its ten-year median of 36.6×, lower than on 93% of days in the last ten years.

Over that time it ranged from 14.5× in Apr 2026 to 79.8× in Jan 2017.

The median for 10 credit services stocks of a similar size is 14.7×.

Price to free cash flow over time

median 36.6×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	17.6×	14.5×	19.5×
2025	19.3×	19.3×	28.8×
2024	24.6×	21.8×	32.1×
2023	25.9×	24.4×	39.6×
2022	37.0×	26.7×	56.1×
2021	26.0×	23.7×	47.6×
2020	38.8×	29.9×	61.5×
2019	51.9×	31.1×	54.7×
2018	38.1×	36.3×	69.8×
2017	39.3×	38.5×	79.8×
2016	67.6×	43.3×	78.7×
2015	68.4×	68.4×	144×

Against its peers

Companies in Financial - Credit Services nearest Healthequity's size, closest first, today.

Company	Price to free cash flow
HQYHealthequity	17.6×
ETSYEtsy	12.3×
ZGZillow	29.7×
WEXWEX	62.0×
EXLSExlService	23.3×
OMFOneMain	n/m
CARTMaplebear	11.1×
CACCCredit Acceptance	4.6×
CSGPCostar	49.1×
AMTMAmentum	11.2×
RELYRemitly Global	14.7×
Peer median	14.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Healthequity

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.